Amazon is looking into opening a supercenter retail location, while closing its Amazon Go and Amazon Fresh physical stores.

NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds F5, Inc. (“F5” or the “Company”) (NASDAQ: FFIV) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join The F5 Class Action Lawsuit?

ORCL is ramping cloud CapEx to $50B as AI and enterprise demand surge, betting GPU-rich data centers can unlock faster revenue growth.

NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Wealthfront Corporation (“Wealthfront” or the “Company”) (NASDAQ: WLTH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

CHICAGO--(BUSINESS WIRE)--ComEd achieved pivotal advancements in 2025 to meet the energy needs of over 9 million people across northern Illinois. While delivering nation-leading electric utility reliability, ComEd connected tens of thousands of customers to renewable energy resources, awarding more than $500 million in rebates and energy efficiency (EE) savings programs to reduce upfront barriers to EVs, solar and battery storage, heat pumps, and energy efficiency savings technologies to help l.

SAN FRANCISCO, Jan. 27, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against BellRing Brands, Inc. (NYSE: BRBR) and certain of its executives. The lawsuit follows BellRing's disastrous May 6, 2025, Q2 2025 and August 4, 2025, Q3 2025 earnings reports, each of which drove the price of BellRing shares sharply lower.

Retail investors have rushed into the iShares Silver Trust (SLV) exchange-traded fund as the metal has surged. One analyst described silver as the new epicenter of retail fervor.

The U.S. Food and Drug Administration (FDA) on Tuesday said it removed the clinical hold on Intellia Therapeutics Inc.‘s (NASDAQ: NTLA) Investigational New Drug application (IND) for the MAGNITUDE-2 Phase 3 trial of nexiguran ziclumeran (nex-z) for hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN).

MDV is an internally managed REIT focused on single-tenant net-lease industrial manufacturing properties, recently increasing its dividend by 2.6%. MDV faces challenges due to specialized assets, high capital costs, and sector-trailing AFFO multiples, limiting its ability to reinvest or grow efficiently. The CEO acknowledges MDV's persistent undervaluation—estimated at 20%-40% below intrinsic value—and is open to strategic alternatives, including a potential sale.

OTIS Q4 performance is likely to have benefited from resilient service growth, but New Equipment sales and China headwinds may have weighed on margins.

Texas Instruments Incorporated (NASDAQ: TXN) will release earnings results for its fourth quarter, after the closing bell on Tuesday, Jan. 27.

IMO gears up to report fourth-quarter results, as earnings and revenue estimates signal mixed trends ahead.

KMB beats fourth-quarter estimates as organic sales rose 2.1%, even as revenues dip from exiting its U.S. private-label diaper business.

Does Deutsche Bank (DB) have what it takes to be a top stock pick for momentum investors? Let's find out.

Workday (WDAY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Enerflex (EFXT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Does Bank of Montreal (BMO) have what it takes to be a top stock pick for momentum investors? Let's find out.

Wintrust (WTFC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Does BOK Financial (BOKF) have what it takes to be a top stock pick for momentum investors? Let's find out.

Apollo Commerical Finance (ARI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).